Table 4.
The top 20 high-impact factors in the two fusion CADVT prediction models
| Stacking | Blending | |||
|---|---|---|---|---|
| rank | Factor type | Factor | Factor type | Factor |
| 1 | Lab test | Standard base excess (SBE)* | Lab test | PH* |
| 2 | Lab test | Thrombin time (TT) difference* | Surgery | Past history* |
| 3 | Drug | Dehydrating agent* | Lab test | Oxygen partial pressure (PaO2)* |
| 4 | Lab test | Bicarbonate* | Lab test | calcium |
| 5 | Lab test | Platelet count | Lab test | Plasma D-dimer (DD)* |
| 6 | Lab test | Oxygen partial pressure (PaO2)* | Lab test | Bicarbonate* |
| 7 | Lab test | Plasma D-dimer (DD)* | Admission ICU | SICU |
| 8 | Lab test | Basophil absolute value* | Lab test | Actual alkali surplus |
| 9 | Lab test | Thrombin time (TT)* | Drug | Dehydrating agent* |
| 10 | Lab test | Carboxyhemoglobin | Drug | Anticoagulant drugs |
| 11 | Vital sign | Diastolic blood pressure | Lab test | Thrombin time (TT) difference* |
| 12 | Surgery | Past history* | Lab test | Thrombin time (TT)* |
| 13 | Lab test | Anion gap | Lab test | Mean hemoglobin concentration |
| 14 | Sex | Male | Catheter model | 18G |
| 15 | Lab test | Lymphocytes (LY%)* | Lab test | Basophil absolute value* |
| 16 | Catheter type | Single lumen | Lab test | Lymphocytes (LY%)* |
| 17 | Diagnosis | Cysts and mass | Catheter type | Double lumen |
| 18 | Lab test | Normal control prothrombin time | diagnosis | Cancer |
| 19 | Vital sign | Blood oxygen saturation | Lab test | Standard base excess (SBE)* |
| 20 | Lab test | PH* | Lab test | Neutrophil absolute value |
* Indicates the overlap in the two fusion models